AMBRA1 and melanoma: The combined immunohistochemical expression of two protein biomarkers, AMBRA1 and Loricrin in the epidermis overlying a primary melanoma as compared with expression in the normal epidermis in the same excision biopsy, has been identified as a novel prognostic biomarker for early AJCC stage I melanomas [7].